PL1885753T3 - Wytwarzanie rekombinowanego białka wiążącego IL-18 - Google Patents
Wytwarzanie rekombinowanego białka wiążącego IL-18Info
- Publication number
- PL1885753T3 PL1885753T3 PL06763472T PL06763472T PL1885753T3 PL 1885753 T3 PL1885753 T3 PL 1885753T3 PL 06763472 T PL06763472 T PL 06763472T PL 06763472 T PL06763472 T PL 06763472T PL 1885753 T3 PL1885753 T3 PL 1885753T3
- Authority
- PL
- Poland
- Prior art keywords
- production
- binding protein
- recombinant
- composition
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68763105P | 2005-06-03 | 2005-06-03 | |
EP05104878 | 2005-06-03 | ||
EP05106429 | 2005-07-13 | ||
EP06763472A EP1885753B1 (en) | 2005-06-03 | 2006-06-01 | Production of recombinant Il-18 binding protein |
PCT/EP2006/062851 WO2006128908A1 (en) | 2005-06-03 | 2006-06-01 | Production of recombinant il-18 binding protein |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1885753T3 true PL1885753T3 (pl) | 2011-12-30 |
Family
ID=44352415
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL06763472T PL1885753T3 (pl) | 2005-06-03 | 2006-06-01 | Wytwarzanie rekombinowanego białka wiążącego IL-18 |
PL10184728T PL2267024T3 (pl) | 2005-06-03 | 2006-06-01 | Wytwarzanie rekombinowanego białka wiążącego IL-18 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL10184728T PL2267024T3 (pl) | 2005-06-03 | 2006-06-01 | Wytwarzanie rekombinowanego białka wiążącego IL-18 |
Country Status (15)
Country | Link |
---|---|
US (2) | US7691611B2 (pl) |
EP (2) | EP1885753B1 (pl) |
JP (2) | JP5199073B2 (pl) |
AT (2) | ATE557038T1 (pl) |
AU (1) | AU2006254103B2 (pl) |
CA (1) | CA2609060C (pl) |
CY (2) | CY1111969T1 (pl) |
DK (2) | DK2267024T3 (pl) |
ES (2) | ES2370417T3 (pl) |
IL (1) | IL187838A (pl) |
NO (1) | NO342802B1 (pl) |
PL (2) | PL1885753T3 (pl) |
PT (2) | PT1885753E (pl) |
SI (2) | SI1885753T1 (pl) |
WO (1) | WO2006128908A1 (pl) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI373343B (en) * | 2000-02-10 | 2012-10-01 | Abbott Gmbh & Co Kg | Antibodies that bind human interleukin-18 and methods of making and using |
US7824907B2 (en) | 2003-03-11 | 2010-11-02 | Merck Serono Sa | Expression vectors comprising the mCMV IE2 promoter |
ATE549353T1 (de) * | 2003-05-13 | 2012-03-15 | Merck Serono Sa | Aktive varianten des il-18 bindenden proteins und dessen medizinische verwendungen |
ES2354160T3 (es) | 2003-10-21 | 2011-03-10 | Merck Serono Sa | Secuencia de adn mínima que actúa como un aislante de cromatina, y su uso en la expresión de proteínas. |
US7820800B2 (en) | 2003-11-05 | 2010-10-26 | Ares Trading S.A. | Process for the purification of IL-18 binding protein |
US7968684B2 (en) | 2003-11-12 | 2011-06-28 | Abbott Laboratories | IL-18 binding proteins |
WO2005083058A1 (en) | 2004-03-01 | 2005-09-09 | Ares Trading S.A. | Use of a serum-free cell culture medium for the production of il-18bp in mammalian cells |
WO2006003134A1 (en) | 2004-06-29 | 2006-01-12 | Ares Trading S.A. | Process for the purification of il-18 binding protein |
SI1891088T1 (sl) | 2005-06-10 | 2012-02-29 | Ares Trading Sa | Postopek za äśiĺ äśenje il-18 vezavnega proteina |
US20160145589A1 (en) | 2011-06-24 | 2016-05-26 | Green Cross Corporation | Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereof |
KR102108663B1 (ko) | 2011-07-01 | 2020-05-07 | 암젠 인크 | 포유동물 세포 배양 |
US9150841B2 (en) | 2012-06-29 | 2015-10-06 | Shire Human Genetic Therapies, Inc. | Cells for producing recombinant iduronate-2-sulfatase |
US20140004097A1 (en) * | 2012-06-29 | 2014-01-02 | Shire Human Genetic Therapies, Inc. | Method of producing recombinant iduronate-2-sulfatase |
KR101380740B1 (ko) | 2012-06-29 | 2014-04-11 | 쉐어 휴먼 제네텍 세러피스, 인코포레이티드 | 이듀로네이트-2-설파타제의 정제 |
US8956830B2 (en) | 2013-03-14 | 2015-02-17 | Momenta Pharmaceuticals, Inc. | Methods of cell culture |
US9217168B2 (en) | 2013-03-14 | 2015-12-22 | Momenta Pharmaceuticals, Inc. | Methods of cell culture |
US9677105B2 (en) * | 2013-03-14 | 2017-06-13 | Momenta Pharmaceuticals, Inc. | Methods of cell culture |
RS59328B1 (sr) * | 2013-03-26 | 2019-10-31 | Coherus Biosciences Inc | Postupak za proizvodnju proteina |
DK3041864T3 (da) | 2013-09-05 | 2021-09-27 | Ab2 Bio Sa | Il-18-bindende protein (il-18bp) ved inflammatoriske sygdomme |
USD759075S1 (en) * | 2014-04-11 | 2016-06-14 | Nutonian, Inc. | Display screen with graphical user interface |
USD759076S1 (en) * | 2014-04-18 | 2016-06-14 | Nutonian, Inc. | Display screen with graphical user interface |
MY194040A (en) | 2015-03-05 | 2022-11-09 | Ab2 Bio Sa | Il-18 binding protein (il-18bp) and antibodies in inflammatory diseases |
KR101789509B1 (ko) * | 2015-11-05 | 2017-10-26 | 주식회사 프로젠 | 재조합 인간 갑상선 자극 호르몬을 포함하는 조성물 및 상기 재조합 인간 갑상선 자극 호르몬의 생산 방법 |
US11193103B2 (en) | 2017-10-16 | 2021-12-07 | Regeneran Pharmaceuticals, Inc. | Perfusion bioreactor and related methods of use |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4588585A (en) | 1982-10-19 | 1986-05-13 | Cetus Corporation | Human recombinant cysteine depleted interferon-β muteins |
US4737462A (en) | 1982-10-19 | 1988-04-12 | Cetus Corporation | Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β |
US4959314A (en) | 1984-11-09 | 1990-09-25 | Cetus Corporation | Cysteine-depleted muteins of biologically active proteins |
US5116943A (en) | 1985-01-18 | 1992-05-26 | Cetus Corporation | Oxidation-resistant muteins of Il-2 and other protein |
US5266476A (en) | 1985-06-18 | 1993-11-30 | Yeda Research & Development Co., Ltd. | Fibrous matrix for in vitro cell cultivation |
US5017691A (en) | 1986-07-03 | 1991-05-21 | Schering Corporation | Mammalian interleukin-4 |
US4879111A (en) | 1986-04-17 | 1989-11-07 | Cetus Corporation | Treatment of infections with lymphokines |
US4965195A (en) | 1987-10-26 | 1990-10-23 | Immunex Corp. | Interleukin-7 |
US4904584A (en) | 1987-12-23 | 1990-02-27 | Genetics Institute, Inc. | Site-specific homogeneous modification of polypeptides |
SG63617A1 (en) | 1991-01-18 | 1999-03-30 | Amgen Boulder Inc | Methods for treating tumar necrosis factor mediated diseases |
JP4306813B2 (ja) * | 1995-09-19 | 2009-08-05 | アスビオファーマ株式会社 | 動物細胞の新規培養方法 |
PT894141E (pt) | 1996-02-20 | 2005-09-30 | Applied Research Systems | Proteinas hibridas que formam heterodimeros |
CA2258721C (en) | 1996-07-12 | 2014-09-09 | Genentech, Inc. | Chimeric heteromultimer adhesins |
IL121860A0 (en) * | 1997-08-14 | 1998-02-22 | Yeda Res & Dev | Interleukin-18 binding proteins their preparation and use |
EP1194539A2 (en) | 1999-06-25 | 2002-04-10 | Universität Zürich | Hetero-associating coiled-coil peptides and screening method therefor |
EP1200124B1 (en) | 1999-07-13 | 2008-09-10 | Bolder Biotechnology, Inc. | Erythropoietin-immunoglobulin fusion proteins |
IL131047A0 (en) | 1999-07-22 | 2001-01-28 | Yeda Res & Dev | Use of il-18 inhibitors |
UA74557C2 (en) * | 1999-09-03 | 2006-01-16 | Applied Research Systems | A method for producing a heterologous secreted protein from chinese hamster ovaries cells grown on microcarriers |
IL151388A0 (en) | 2000-02-21 | 2003-04-10 | Applied Research Systems | Use of il-18 inhibitors |
HU229375B1 (en) | 2000-05-05 | 2013-11-28 | Inst Nat Sante Rech Med | Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis |
IL140110A0 (en) * | 2000-12-05 | 2002-02-10 | Applied Research Systems | Improvement of homogeneity and secretion of recombinant proteins in mammalian systems |
KR100857376B1 (ko) | 2001-01-29 | 2008-09-05 | 라보라토리스 세로노 에스.에이. | 심장 질환의 치료 및/또는 예방에 사용되는 il-18저해물질 |
BRPI0207933B8 (pt) | 2001-03-08 | 2021-05-25 | Ares Trading Sa | polipeptídeo mutante de interleucina-18 e composição farmacêutica |
EA009125B1 (ru) | 2001-05-16 | 2007-10-26 | Йеда Рисерч Энд Дивелопмент Ко., Лтд. | Применение ингибиторов il-18 для лечения и/или предупреждения заболеваний, характерных для синдрома системной воспалительной реакции |
EA006744B1 (ru) | 2001-05-25 | 2006-04-28 | Арес Трейдинг С. А. | Применение ингибиторов il-18 для лечения и предотвращения повреждений цнс |
UA78516C2 (en) | 2001-08-10 | 2007-04-10 | Applied Research Systems | Use of inhibitors of il-18 for treatment and/or prevention of hypersensitivity disorders, and in particular of delayed-type hypersensitivity |
JP4885424B2 (ja) | 2002-03-22 | 2012-02-29 | メルク セロノ ソシエテ アノニム | 末梢脈管疾患の治療および/または予防のためのil−18阻害剤の使用 |
US20070092933A1 (en) | 2002-08-14 | 2007-04-26 | Avidis Sa | Production of multimeric fusion proteins using a c4bp scaffold |
CA2501459A1 (en) | 2002-10-11 | 2004-04-22 | Zymogenetics, Inc. | Production of homotrimeric fusion proteins |
CA2511520A1 (en) * | 2002-12-23 | 2004-07-15 | Bristol-Myers Squibb Company | Mammalian cell culture processes for protein production |
US7824907B2 (en) | 2003-03-11 | 2010-11-02 | Merck Serono Sa | Expression vectors comprising the mCMV IE2 promoter |
ATE549353T1 (de) | 2003-05-13 | 2012-03-15 | Merck Serono Sa | Aktive varianten des il-18 bindenden proteins und dessen medizinische verwendungen |
ES2354160T3 (es) | 2003-10-21 | 2011-03-10 | Merck Serono Sa | Secuencia de adn mínima que actúa como un aislante de cromatina, y su uso en la expresión de proteínas. |
US7820800B2 (en) * | 2003-11-05 | 2010-10-26 | Ares Trading S.A. | Process for the purification of IL-18 binding protein |
WO2005083058A1 (en) | 2004-03-01 | 2005-09-09 | Ares Trading S.A. | Use of a serum-free cell culture medium for the production of il-18bp in mammalian cells |
WO2006003134A1 (en) | 2004-06-29 | 2006-01-12 | Ares Trading S.A. | Process for the purification of il-18 binding protein |
SI1891088T1 (sl) | 2005-06-10 | 2012-02-29 | Ares Trading Sa | Postopek za äśiĺ äśenje il-18 vezavnega proteina |
-
2006
- 2006-06-01 PT PT06763472T patent/PT1885753E/pt unknown
- 2006-06-01 SI SI200631144T patent/SI1885753T1/sl unknown
- 2006-06-01 DK DK10184728.3T patent/DK2267024T3/da active
- 2006-06-01 ES ES06763472T patent/ES2370417T3/es active Active
- 2006-06-01 ES ES10184728T patent/ES2385639T3/es active Active
- 2006-06-01 SI SI200631379T patent/SI2267024T1/sl unknown
- 2006-06-01 PL PL06763472T patent/PL1885753T3/pl unknown
- 2006-06-01 EP EP06763472A patent/EP1885753B1/en active Active
- 2006-06-01 US US11/915,453 patent/US7691611B2/en active Active
- 2006-06-01 PL PL10184728T patent/PL2267024T3/pl unknown
- 2006-06-01 WO PCT/EP2006/062851 patent/WO2006128908A1/en not_active Application Discontinuation
- 2006-06-01 PT PT10184728T patent/PT2267024E/pt unknown
- 2006-06-01 AT AT10184728T patent/ATE557038T1/de active
- 2006-06-01 CA CA2609060A patent/CA2609060C/en active Active
- 2006-06-01 AU AU2006254103A patent/AU2006254103B2/en active Active
- 2006-06-01 JP JP2008514112A patent/JP5199073B2/ja active Active
- 2006-06-01 DK DK06763472.5T patent/DK1885753T3/da active
- 2006-06-01 EP EP10184728A patent/EP2267024B1/en active Active
- 2006-06-01 AT AT06763472T patent/ATE517917T1/de active
-
2007
- 2007-12-03 IL IL187838A patent/IL187838A/en active IP Right Grant
- 2007-12-27 NO NO20076672A patent/NO342802B1/no unknown
-
2010
- 2010-02-15 US US12/705,773 patent/US20100137195A1/en not_active Abandoned
-
2011
- 2011-10-27 CY CY20111101026T patent/CY1111969T1/el unknown
-
2012
- 2012-06-29 CY CY20121100583T patent/CY1113056T1/el unknown
- 2012-11-09 JP JP2012247547A patent/JP5837476B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
SI1885753T1 (sl) | 2011-12-30 |
US20080199913A1 (en) | 2008-08-21 |
EP1885753A1 (en) | 2008-02-13 |
CY1113056T1 (el) | 2016-04-13 |
EP1885753B1 (en) | 2011-07-27 |
DK2267024T3 (da) | 2012-06-25 |
NO342802B1 (no) | 2018-08-06 |
CY1111969T1 (el) | 2015-11-04 |
NO20076672L (no) | 2008-02-22 |
SI2267024T1 (sl) | 2012-09-28 |
DK1885753T3 (da) | 2011-10-03 |
US7691611B2 (en) | 2010-04-06 |
AU2006254103A1 (en) | 2006-12-07 |
ATE557038T1 (de) | 2012-05-15 |
ATE517917T1 (de) | 2011-08-15 |
PT2267024E (pt) | 2012-06-01 |
IL187838A0 (en) | 2008-03-20 |
EP2267024B1 (en) | 2012-05-09 |
PL2267024T3 (pl) | 2012-10-31 |
JP5837476B2 (ja) | 2015-12-24 |
WO2006128908A1 (en) | 2006-12-07 |
ES2370417T3 (es) | 2011-12-15 |
US20100137195A1 (en) | 2010-06-03 |
EP2267024A1 (en) | 2010-12-29 |
JP2008541748A (ja) | 2008-11-27 |
CA2609060A1 (en) | 2006-12-07 |
CA2609060C (en) | 2014-07-15 |
JP2013048633A (ja) | 2013-03-14 |
JP5199073B2 (ja) | 2013-05-15 |
PT1885753E (pt) | 2011-10-06 |
ES2385639T3 (es) | 2012-07-27 |
IL187838A (en) | 2011-07-31 |
AU2006254103B2 (en) | 2012-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1885753E (pt) | Produção de proteína recombinante de ligação a il-18 | |
HK1120052A1 (en) | Process for the preparation of glycosylated interferon beta | |
ZA200705874B (en) | Process for producing polypeptide mixtures using hydrogenolysis | |
EP1897951A3 (en) | Composition and methods for producing steviol and steviol glycosides | |
EP1970399A4 (en) | METHOD FOR PRODUCING A POLYGLYCOLIC ACID RESIN COMPOSITION | |
EP1811027A4 (en) | POLYNUCLEOTIDE FOR THE PRODUCTION OF RECOMBINANT PROTEIN THROUGH SILICONS | |
IL187935A0 (en) | Process for the purification of il-18 binding protein | |
EP1950191A4 (en) | PROCESS FOR PRODUCING 3,3,3-TRIFLUOROPROPIONIC ACID | |
EP1748071A4 (en) | PROCESS FOR PRODUCTION OF POLYPEPTIDE | |
EP1862079A4 (en) | PROCESS FOR PRODUCING SOY PROTEIN | |
ZA200711011B (en) | A recombinant method for production of an erythropoiesis stimulating protein | |
HK1119188A1 (en) | Recombinant production of heparin binding proteins | |
ZA200803138B (en) | Bioleaching process control | |
ZA200801497B (en) | Methionine producing recombinant microorganisms | |
EP2261243A3 (en) | Hemopexin-like structure as polypeptide-scaffold | |
EP1930310A4 (en) | PROCESS FOR PRODUCING 3,3,3-TRIFLUOROPROPIONALDEHYDE | |
PL3284458T3 (pl) | Sposób wytwarzania pastylek do ssania zawierających NLPZ | |
EP1852518A4 (en) | METHOD FOR PRODUCING MULTIFUNCTIONAL MATERIAL | |
PL1627881T3 (pl) | Sposób otrzymywania topiramatu | |
EP1935981A4 (en) | PROCESS FOR PRODUCING RECOMBINANT PROTEIN | |
ZA200711006B (en) | A process comprising codon optimization for the production of recombinant activated human protein c for the treatment of sepsis | |
EP1860207A4 (en) | TARGET PROCESS | |
MD2572F1 (en) | Process for obtaining tomato recombinant forms | |
ZA200805149B (en) | Recombinant production of heparin binding proteins | |
WO2008098693A3 (en) | Convergent synthesis of glp-1 |